
Sign up to save your podcasts
Or


Rina and Jean look ahead to UK pharma compliance in 2026, including likely complaint hotspots, familiar risk areas and the big question of PMCPA modernisation.
By Code ClarityRina and Jean look ahead to UK pharma compliance in 2026, including likely complaint hotspots, familiar risk areas and the big question of PMCPA modernisation.